2374 Multivariate analysis of progression-free survival in the CLARINET study of lanreotide Autogel/Depot vs placebo identifies prognostic factors in neuroendocrine tumours. (September 2015) - Wolin, E.; Caplin, M.; Pavel, M.; Cwikła, J.; Phan, A.; Raderer, M.; Sedláčková, E.; Cadiot, G.; Capdevila, J.; Wall, L.; Rindi, G.; Langley, A.; et al.